Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Clinical trial NCT04020263 · RECRUITING
Trial details
- NCT number
- NCT04020263
- Sponsor
- Pr Bruno LEVY
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2027-02-03
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.